We need to cap price of insulin
To the Editor:
Late last week the U.S. House of Representatives passed HR 6833, a bill that caps the price of insulin at $35 per month. Now it goes to the Senate for approval.
An important thing to know is that our 11th District representative, Madison Cawthorn, was one of 193 Republicans who voted against capping the price. Cawthorn’s vote is in the official roll call vote in the Congressional Record. You can look it up for yourself. By his vote, he is saying that he doesn’t want you to be able to afford your life-saving insulin. Don’t believe him if he tries to tell you he is working for your best interest. The Bible says it is “by your works that you shall be known,” not words. His votes are his “words.” We all know how trustworthy his words are anyway.
Just for perspective, insulin has been around for decades and costs less than $10 to manufacture. So why are some paying as much as $300 for it? It is because just three companies control 90 percent of the market and they collude to get away with it. A cap of $35 is still a more generous profit margin than most of your small businesses make. A price of $300 is just outrageous corporate greed that needs to be stopped.
The Senate still has to pass the bill that caps the price at $35. Everyone who thinks capping the price of insulin is a good idea needs to be calling our two senators, Thom Tillis and Richard Burr, every day to tell them to vote to support the cap.